Company News
Company News
On May 10, 2023, we celebrated the grand opening of CIRS Kexin Biotech.* It has taken more than one year of industrial surveys but we were proud to finally open the new company on May 10, 2023.
A breakthrough study on the anti-photodamage effects of Gardenia Fructus Extracts, jointly conducted by Hangzhou CIRS KEXIN Biotech Co., Ltd. (CIRS Biotech) and Shanghai Junyu Biotechnology Co., Ltd. (Junyu Group), has been published in Cosmetics, an internationally renowned SCI-indexed journal. The breakthrough study provides scientific validation for the development of photoprotective ingredients and the establishment of its efficacy evaluation systems.
We are excited to announce a new strategic cooperation agreement between CIRS Europe and EPY S.R.L, an Italian software company specializing in regulatory compliance solutions. This partnership marks a significant step in enhancing regulatory support and digital solutions for businesses navigating complex compliance requirements.
On February 18, 2025, the Korea Cosmetic Industry Institute (KCII) announced the list of implementing agencies for the 2025 Global Cosmetics Regulatory Consulting Support Program. CIRS Group Korea, the South Korean subsidiary of CIRS Group, has once again been successfully selected. This marks the sixth consecutive year that CIRS Group Korea has been chosen as an implementing agency for this program, demonstrating the company's expertise and influence in the field of global cosmetics regulations.
On January 22, 2025, CIRS Japan (Japanese name: CIRSジャパン株式會社) was officially established in Tokyo. As another subsidiary of CIRS Group in Asia, the establishment of CIRS Japan marks a significant milestone for CIRS Group’s global strategic layout.
Hangzhou CIRS C&K Testing Technology Co., Ltd. officially inaugurated its new toxicology laboratory in August. Located in the Tianhe High-tech Industrial Park in the Binjiang District of Hangzhou, Zhejiang Province, this lab is to provide toxicological tests and research services to industries such as cosmetics, medical devices, health products, specialty foods, and pharmaceuticals.
On May 9, 2023, Hangzhou C&K Testing Technic Co., Ltd. (C&K Testing), a wholly-owned subsidiary of CIRS Group celebrated its tenth anniversary.
CIRS Testing Korea (YU) has been accredited in accordance with the recognized International Standard ISO/IEC 17025:2017 and is qualified to provide physical and chemical properties testing as well as hazardous substances analysis, which are necessary for substance registration and K-BPR notification.
Since its establishment in 2007, CIRS Group has focused on product regulatory compliance services, helping clients gain a competitive advantage by reducing business risks associated with regulatory affairs. After 15 years of development, CIRS Group has expanded its business across multiple industries to include: chemicals, cosmetics, food and beverages, medical devices, agrochemical products, disinfectants, and consumer goods.
Contact Us
Quick Navigation